TipRanks
CytoDyn (DE:296)
STUTTGART:296

Compare CytoDyn (296) vs. Competitors

0 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
CytoDyn
€0.17
€261.50M
-5.80
-15.18%
―
Agenus
$8.36
$394.26M
2.76
80.48%
4 Buy
0 Hold
0 Sell
Strong Buy
Coherus Biosciences
$1.37
$173.04M
-1.01
-39.41%
4 Buy
0 Hold
0 Sell
Strong Buy
MacroGenics
$4.04
$240.15M
-16.55
106.82%
2 Buy
2 Hold
0 Sell
Moderate Buy
ADC Therapeutics
$1.05
$157.03M
-1.92
-71.33%
1 Buy
1 Hold
0 Sell
Moderate Buy
OmniAb
$4.47
$715.32M
-12.08
158.93%
5 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:296
CytoDyn
0.19
-0.03
-15.18%
AGEN
Agenus
7.49
3.24
76.24%
CHRS
Coherus Biosciences
1.03
-0.68
-39.77%
MGNX
MacroGenics
3.64
1.92
111.63%
ADCT
ADC Therapeutics
1.27
-3.04
-70.53%
OABI
OmniAb
4.35
2.70
163.64%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts